Belgian cost-utility analysis of Lucentis (ranibizumab) in wet age-related macular degeneration. |
Author(s): Moeremans K, Annemans L, Lecomte P |
Affiliations(s): |
Publication(s): ISPOR 10th Annual European Congress, 2007, October 20-23, Dublin, Ireland
|
Document Type(s): Poster, |
Countries: Belgium, |
C: Y: |
Ophthalmology, 2007 |
|
L: A: |
English Cost utility, |
|
|
|
|
The impact of glaucoma coding in a large claims database. |
Author(s): Lee P, Levin L, Walt J, Chiang T, Doyle J, Stern L, Dolgitser M
|
Affiliations(s): |
Publication(s): American Journal of Ophthalmology, 2007, 143(5): 867-70
|
Document Type(s): Article, |
Countries: USA, |
Click here for the abstract |
C: Y: |
Ophthalmology, 2007 |
|
L: A: |
English Retrospective database analysis, |
|
|
|
|
11 of 11
|